Skip to content

Medical emergency? What to do

Cheaper blood thinner just as effective, study says

3-RXPublished August 24, 20062 min read

Key points

  • Injections of the blood thinner heparin treat blood clots just as effectively as a top-selling version that is many times more expensive, researchers said on Tuesday.
  • The original blood thinner, called unfractionated heparin and derived from pig tissues, is given intravenously in the hospital and patients are closely monitored.
  • But the study by McMaster University researchers found a weight-adjusted dosage of the original, much-cheaper heparin -- a six-day course would cost $37 versus $712 for low-molecular-weight heparin -- can be injected twice daily without an expensive hospital stay or in-hospital testing.
  • Blood clots reappeared in less than 4 percent of 700 patients whether they injected the original heparin or low-molecular weight heparin.

Injections of the blood thinner heparin treat blood clots just as effectively as a top-selling version that is many times more expensive, researchers said on Tuesday.

To treat deep vein thrombosis, which appears most often as blood clots in the legs, injections of low-molecular weight heparin such as Sanofi-Aventis' blockbuster Lovenox and Pfizer's Fragmin have been increasingly seen as more convenient and effective than original heparin.

The original blood thinner, called unfractionated heparin and derived from pig tissues, is given intravenously in the hospital and patients are closely monitored.

The newer, more expensive version of heparin is extracted from the original and has smaller molecules, meaning it is less likely to bind to a protein in the body and presumably making it more predictable and convenient to use. It is injected just once a day, and can be administered by the patient.

But the study by McMaster University researchers found a weight-adjusted dosage of the original, much-cheaper heparin -- a six-day course would cost $37 versus $712 for low-molecular-weight heparin -- can be injected twice daily without an expensive hospital stay or in-hospital testing.

"That was the underlying reason why we did the study: it is not necessary to do blood testing," study author Clive Kearon said in a telephone interview.

Blood clots reappeared in less than 4 percent of 700 patients whether they injected the original heparin or low-molecular weight heparin. The rate of major bleeding was also comparable in the two groups.

"This study will open the possibility of an expanded role for inexpensive, ordinary heparin," Kearon said, noting that most such studies are sponsored by drug companies that may be less motivated to recommend a treatment that costs less.

The study, which was published in the Journal of the American Medical Association, was funded by The Heart and Stroke Foundation of Ontario.

"If you never do a study funded by a peer-reviewed agency, you're never going to reduce the cost of therapy," Kearon said.

The difference in cost of the two blood thinners is not as great in Canada or in Europe, where low-molecular weight heparin is more commonly used.

According to The American Heart Association, deep vein thrombosis occurs in about 2 million Americans a year and an estimated 600,000 of those develop a pulmonary embolism in the

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.